NCT03036930 2026-04-13
Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients
National Cancer Institute (NCI)
Phase 2 Active not recruiting
Clinical Trials
6 trialsNCT05087849 2025-10-02
Intralesional HPV Vaccine for Condylomata
University of California, San Francisco
Phase 1/2 Completed
NCT01824537 2025-03-19
TRAP-HPV
McGill University
Phase 4 Completed
NCT05496231 2025-02-03
A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of Age
GlaxoSmithKline
Phase 1/2 Completed
NCT03051516 2024-02-28
HPV Vaccine Therapy in Interrupting Progression in Patients With High-Grade Vulvar or Anal Lesions
Fred Hutchinson Cancer Center
Phase 4 Terminated
NCT01492582 2021-10-27
Vaccine Therapy in Preventing Human Papillomavirus Infection in Younger Cancer Survivors
University of Alabama at Birmingham
Phase 2 Completed